MYLIP and atherosclerosis: Previous studies have shown that transgenic mice overexpressing human Idol developed visible atherosclerotic lesions [13, 25]; however, whether genetical or pharmaceutical inhibition of Idol could yield a promising outcome of ASCVD has not been fully addressed yet.